Norvasc REDUCES the risk of heart attack and stroke
January 1999
There's new evidence that Norvasc REDUCES the risk of heart attack and stroke...in patients with coronary artery disease.
This is especially important because of all the news a few years ago about a HIGHER risk of heart attack with some calcium blockers...mostly SHORT-acting nifedipine.
This sparked a lot of research on LONG-acting calcium blockers...Norvasc (amlodipine), Plendil (felodipine), etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote